Harrow Inc 's ability to collect accounts receivable sequentially worsen to 2.69, indicating more challenging environment then in the first quarter 2026, but still, it is a far cry from any concerns. Harrow Inc 's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 136 days, from 126 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 192 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1460, from overall ranking in the first quarter 2026 at 2028.

What is Receivable Turnover Ratio?
What is Harrow Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

HROW Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	50.41 %	31.4 %	-4.71 %	44.42 %	51.62 %
Y / Y Revenue Change	11.26 %	-6.9 %	33.31 %	44.04 %	31.22 %
Receivable Turnover Ratio (TTM)	2.69	2.9	3.15	2.84	2.78
HROW's Total Ranking	# 1460	# 2028	# 923	# 1298	# 1053
Accounts Receivable average collection period days	136	126	116	128	131
Seq. Receivable Change	17.08 %	-8.69 %	42.91 %	-1.55 %	2.28 %
Seq. Revenue Change	60.43 %	-50.56 %	25.61 %	11.67 %	34.25 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 49
Healthcare Sector	# 193
Overall Market	# 1460

Receivable Turnover Ratio Statistics
High	Average	Low
1.5	0.72	0
(Sep 30 2018)		(Mar 31 2014)

HROW Company Profile • Back to HROW Efficiency Comparisons • Compare HROW Receivables Turnover Ratio to its Competitors

Financial Statements
Harrow Inc 's Accounts Receivable	$ 119 Millions	Visit HROW's Balance sheet
Harrow Inc 's Sales TTM	$ 275 Millions	Visit HROW's Income Statement
Sources of HROW's Revenues		Visit HROW's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
HROW's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
HROW's Growth Rates	HROW's Roa	HROW's Inventory Turnover Ratio	HROW's Dividend Comparisons
HROW's Profitability Ratios	HROW's Roi	HROW's Asset Turnover Ratio	HROW's Dividend Growth
HROW's Valuation Ratios	HROW's Roe	HROW's Financial Strength Ratios	HROW's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Baxter International Inc	6.37	$ 11,555.000 Millions	$ 1,814.250 Millions
Edap Tms Sa	6.34	$ 111.051 Millions	$ 17.522 Millions
Syndax Pharmaceuticals Inc	6.32	$ 252.004 Millions	$ 39.902 Millions
Nuwellis Inc	6.28	$ 9.013 Millions	$ 1.435 Millions
Puma Biotechnology Inc	6.27	$ 231.244 Millions	$ 36.902 Millions
Absci Corp	6.24	$ 1.561 Millions	$ 0.250 Millions
Insulet Corporation	6.24	$ 3,053.400 Millions	$ 489.200 Millions
Perrigo Company Plc	6.22	$ 4,144.000 Millions	$ 666.050 Millions
Maxcyte inc	6.22	$ 31.051 Millions	$ 4.994 Millions
Cue Biopharma Inc	6.21	$ 37.654 Millions	$ 6.064 Millions
Heartflow Inc	6.20	$ 210.791 Millions	$ 33.999 Millions
Omada Health Inc	6.20	$ 308.445 Millions	$ 49.770 Millions
Vertex Pharmaceuticals Inc	6.19	$ 12,587.200 Millions	$ 2,032.400 Millions
Orthofix Medical Inc	6.17	$ 833.344 Millions	$ 135.037 Millions
Harvard Bioscience Inc	6.16	$ 88.164 Millions	$ 14.306 Millions
Genedx Holdings Corp	6.16	$ 455.446 Millions	$ 73.962 Millions
Gilead Sciences Inc	6.15	$ 30,457.000 Millions	$ 4,951.000 Millions
Integra Lifesciences Holdings Corp	6.14	$ 1,647.666 Millions	$ 268.153 Millions
Zoetis Inc	6.13	$ 9,517.000 Millions	$ 1,552.000 Millions
Interpace Biosciences Inc	6.12	$ 36.519 Millions	$ 5.963 Millions
Xeris Biopharma Holdings Inc	6.12	$ 335.414 Millions	$ 54.800 Millions
Treace Medical Concepts Inc	6.12	$ 205.307 Millions	$ 33.551 Millions
Zevra Therapeutics Inc	6.09	$ 128.855 Millions	$ 21.172 Millions
Aquestive Therapeutics Inc	6.08	$ 54.087 Millions	$ 8.891 Millions
Femasys Inc	6.08	$ 2.299 Millions	$ 0.378 Millions
Sharps Technology Inc	6.07	$ 1.960 Millions	$ 0.323 Millions
Lakeland Industries Inc	6.07	$ 190.961 Millions	$ 31.455 Millions
Labcorp Holdings Inc	6.05	$ 14,348.000 Millions	$ 2,370.300 Millions
Neogen Corporation	6.05	$ 870.190 Millions	$ 143.936 Millions
Monte Rosa Therapeutics Inc	6.02	$ 28.727 Millions	$ 4.774 Millions

Date modified: 2026-08-12T20:12:17+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.